Kronos Bio Inc (KRON)
0.963
-0.04
(-3.70%)
USD |
NASDAQ |
Jan 06, 16:00
0.963
0.00 (0.00%)
After-Hours: 20:00
Kronos Bio Shareholders Equity (Quarterly): 111.13M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Alnylam Pharmaceuticals Inc | 32.35M |
| PTC Therapeutics Inc | -1.054B |
| Soleno Therapeutics Inc | 264.70M |
| PMV Pharmaceuticals Inc | 197.91M |
| CEL-SCI Corp | 8.473M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 150.02M |
| Total Liabilities (Quarterly) | 38.90M |
| Current Ratio | 8.316 |